Advertisement
Singapore markets closed
  • Straits Times Index

    3,280.10
    -7.65 (-0.23%)
     
  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • Bitcoin USD

    63,682.15
    -476.99 (-0.74%)
     
  • CMC Crypto 200

    1,322.14
    -74.40 (-5.33%)
     
  • S&P 500

    5,103.99
    +55.57 (+1.10%)
     
  • Dow

    38,253.06
    +167.26 (+0.44%)
     
  • Nasdaq

    15,932.28
    +320.52 (+2.05%)
     
  • Gold

    2,349.40
    +6.90 (+0.29%)
     
  • Crude Oil

    84.06
    +0.49 (+0.59%)
     
  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     
  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     
  • Jakarta Composite Index

    7,036.08
    -119.22 (-1.67%)
     
  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Why Vertex Pharmaceuticals Stock Was Soaring Today

An estimates-beating quarter and raised guidance were the elements pushing Vertex Pharmaceuticals (NASDAQ: VRTX) shares comfortably higher on Friday. After market hours on Thursday, Vertex published its second-quarter results. Vertex's growth was powered by its current blockbuster drug, Trikafta.